Details of the Drug Reposition

General Information of This Drug (ID: DMP0TQA)

Drug Name
LV305   DMP0TQA
Synonyms NY-ESO-1 Zvex

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 1 [1]
Melanoma DIS1RRCY 2C30 Phase 1 [1]
Breast cancer DIS7DPX1 2C60-2C65 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02122861) A Phase 1 Safety Study of Intradermal ID-LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1. U.S. National Institutes of Health.